Groupe Bruxelles Lambert Invests $62.16 Billion in Concentrix Corporation $CNXC

Groupe Bruxelles Lambert bought a new stake in Concentrix Corporation (NASDAQ:CNXC) in the 2nd quarter, HoldingsChannel.com reports. The institutional investor bought 2,773,667 shares of the company’s stock, valued at approximately $62,157,877,000. Concentrix accounts for about 100.0% of Groupe Bruxelles Lambert’s investment portfolio, making the stock its largest holding.

A number of other large investors also recently made changes to their positions in the company. Kopernik Global Investors LLC purchased a new position in Concentrix during the first quarter worth about $44,523,000. AQR Capital Management LLC increased its stake in Concentrix by 25.5% in the 2nd quarter. AQR Capital Management LLC now owns 4,305,469 shares of the company’s stock valued at $226,252,000 after buying an additional 875,556 shares during the last quarter. Bank of New York Mellon Corp purchased a new stake in Concentrix in the 2nd quarter valued at about $16,654,000. Pzena Investment Management LLC lifted its position in shares of Concentrix by 32.3% during the 4th quarter. Pzena Investment Management LLC now owns 2,927,196 shares of the company’s stock worth $121,713,000 after buying an additional 714,604 shares in the last quarter. Finally, Quantinno Capital Management LP lifted its position in shares of Concentrix by 171.4% during the 1st quarter. Quantinno Capital Management LP now owns 1,076,413 shares of the company’s stock worth $29,451,000 after buying an additional 679,749 shares in the last quarter. 90.34% of the stock is owned by institutional investors.

Concentrix Stock Performance

Shares of CNXC stock opened at $24.49 on Monday. The company has a debt-to-equity ratio of 1.46, a quick ratio of 1.18 and a current ratio of 1.18. The firm has a market cap of $1.49 billion, a price-to-earnings ratio of -1.15, a P/E/G ratio of 0.45 and a beta of 0.45. Concentrix Corporation has a 52 week low of $19.12 and a 52 week high of $57.88. The firm’s 50-day simple moving average is $24.61 and its two-hundred day simple moving average is $27.94.

Concentrix (NASDAQ:CNXC) last released its earnings results on Monday, June 29th. The company reported $2.63 earnings per share for the quarter, missing analysts’ consensus estimates of $2.64 by ($0.01). Concentrix had a negative net margin of 13.16% and a positive return on equity of 19.82%. The company had revenue of $2.46 billion for the quarter, compared to the consensus estimate of $2.47 billion. During the same period in the prior year, the company earned $2.70 earnings per share. The firm’s revenue was up 1.9% on a year-over-year basis. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. As a group, equities analysts forecast that Concentrix Corporation will post 9.67 earnings per share for the current year.

Concentrix Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, August 4th. Investors of record on Friday, July 24th were paid a $0.36 dividend. The ex-dividend date was Friday, July 24th. This represents a $1.44 annualized dividend and a yield of 5.9%. Concentrix’s dividend payout ratio is presently -6.75%.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on CNXC shares. Barrington Research reduced their target price on Concentrix from $38.00 to $30.00 and set an “outperform” rating for the company in a report on Tuesday, June 30th. Bank of America dropped their price target on Concentrix from $32.00 to $26.00 and set a “neutral” rating on the stock in a report on Tuesday, June 30th. Robert W. Baird cut their price objective on Concentrix from $40.00 to $30.00 and set an “outperform” rating on the stock in a research report on Tuesday, June 30th. Weiss Ratings reissued a “sell (d)” rating on shares of Concentrix in a research report on Friday, July 24th. Finally, Zacks Research downgraded Concentrix from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 2nd. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $32.75.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.